Gemcitabine/5-FU/leucovorin for the treatment of pancreatic cancer

Autor:	F Ranjpoor, A R Maadi, R Malayeri, M Ghassem Boland
Rok vydání:	2008
Předmět:	Oncology Cancer Research medicine.medical_specialty Chemotherapy business.industry medicine.medical_treatment Disease medicine.disease Gemcitabine Internal medicine Pancreatic cancer medicine Pancreatic carcinoma business medicine.drug
Zdroj:	Journal of Clinical Oncology. 26:15651-15651
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2008.26.15_suppl.15651
Popis:	15651 Background: Until now, there is no standard chemotherapy protocol for pancreatic cancer. As this disease is very hard to treat and most studies have shown low response rates and survival, we ...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::31b6fcfa994b4ead8854d826d39ba86f https://doi.org/10.1200/jco.2008.26.15_suppl.15651 Zobrazit plný text záznamu